Omada Health, a provider of virtual care between medical visits, announced preliminary unaudited financial results for the fourth quarter and full year 2025[1][2]. Revenues for the fourth quarter of 2025 are expected to reach $72 million to $74 million, representing an increase of 50 to 54% over the same period in 2024[1][2]. For the full year 2025, it expects revenues of 256 to 258 million dollars, i.e. growth of 51 to 52% compared to 2024[1][2]. The number of members reached approximately 886,000 as of December 31, 2025, an increase of 55% from the previous year[1][2]. In 2025, the company expanded its care offerings to include GLP-1 drugs and advanced the use of artificial intelligence on the platform[1][2]. These results underscore the growing relevance of the between-visit care model, said co-founder and CEO Sean Duffy[1][2]. The final audited results will be published on March 5, 2026 after the market closes[4][5]. In the third quarter of 2025, the company achieved revenues of $61 million with annual growth of 49%, supported by the GLP-1 program[3].